FDA Inspection 593761 — New York Presbyterian Hospital Weill Cornell Medical College

New York Presbyterian Hospital Weill Cornell Medical College — FEI 3003972369

The FDA completed an inspection of New York Presbyterian Hospital Weill Cornell Medical College on June 24, 2009 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 24, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible